Completed PHASE3 INTERVENTIONAL 2-arm NCT03702946

Oxytocin Infusion and Abdominal Myomectomy

Effect of Oxytocin Infusion on Reducing the Blood Loss During Abdominal Myomectomy: A Randomized Controlled Trial

Sponsor: Armed Forces Hospital, Pakistan

Conditions Oxytocin and Abdominal Myomectomy

Interventions oxytocin in abdominal myomectomy

Updated 4 times since 2018 Last updated: Oct 9, 2018 Started: Jul 15, 2017 Primary completion: Jan 15, 2018 Completion: Jan 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Oxytocin and Abdominal Myomectomy, this trial is completed. The trial is conducted by Armed Forces Hospital, Pakistan and has accumulated 4 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Nov 2018 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Armed Forces Hospital, Pakistan

Data source: Armed Forces Hospital, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rawalpindi, Pakistan